Trivascular Technologies, Inc. Receivables Turnover Ratio (TRIV), from the third quarter 2015 to the third quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Trivascular Technologies, Inc.  (TRIV)
 

Trivascular Technologies Accounts Receivables Turnover Ratio from the third quarter 2015 to the third quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Trivascular Technologies, Inc.'s ability to collect accounts receivable sequentially worsen to 5.56, indicating more challenging environment then in the second quarter 2015, but still, it is a far cry from any concerns. Trivascular Technologies's Accounts Receivable average collection period in the Sep 30 2015 quarter, has increased to 66 days, from 64 days, in the Jun 30 2015 quarter.

If we take a look into Healthcare sector 254 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2682, from overall ranking in the second quarter 2015 at 2796.

What is Receivable Turnover Ratio?
What is Trivascular Technologies, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIV Receivables Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Receivable Change 34.78 % 20.21 % 10.89 % 38.47 % -
Y / Y Revenue Change 20.02 % 24.81 % 14.09 % 45.76 % 43.11 %
Receivable Turnover Ratio (TTM) 5.56 5.69 5.64 5.61 5.55
TRIV's Total Ranking # 2682 # 2796 # 2679 # 2798 # 0
Accounts Receivable average collection period days 66 64 65 65 66
Seq. Receivable Change -3 % 10.65 % -6.34 % 34.06 % -13.48 %
Seq. Revenue Change -2.86 % 21.28 % -11.7 % 15.36 % 1.03 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 255
Overall Market # 2682

Receivable Turnover Ratio Statistics
High Average Low
0.4 0.34 0.3
(Sep 30 2015)   (Mar 31 2015)





TRIV Company Profile • Back to TRIV Efficiency Comparisons • Compare TRIV Receivables Turnover Ratio to its Competitors

Financial Statements
Trivascular Technologies's Accounts Receivable $ 7 Millions Visit TRIV's Balance sheet
Trivascular Technologies's Sales TTM $ 36 Millions Visit TRIV's Income Statement
Sources of TRIV's Revenues Visit TRIV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TRIV's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TRIV's Growth Rates TRIV's Roa TRIV's Inventory Turnover Ratio TRIV's Dividend Comparisons
TRIV's Profitability Ratios TRIV's Roi TRIV's Asset Turnover Ratio TRIV's Dividend Growth
TRIV's Valuation Ratios TRIV's Roe TRIV's Financial Strength Ratios TRIV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Receivable at quarter ending Sep 30 2015
Harrow Inc   15.05 $ 6.763  Millions$ 0.449  Millions
Veracyte Inc   14.99 $ 47.660  Millions$ 3.180  Millions
Biocorrx Inc   14.80 $ 1.220  Millions$ 0.082  Millions
Epizyme Inc.  14.80 $ 12.354  Millions$ 0.835  Millions
Oncomed Pharmaceuticals Inc  14.78 $ 27.575  Millions$ 1.866  Millions
Miragen Therapeutics Inc   14.59 $ 3.625  Millions$ 0.249  Millions
Semler Scientific inc   14.51 $ 5.122  Millions$ 0.353  Millions
Apyx Medical Corp  14.42 $ 28.691  Millions$ 1.989  Millions
Wearable Health Solutions, Inc.  14.19 $ 1.205  Millions$ 0.085  Millions
Sanuwave Health Inc   14.17 $ 0.831  Millions$ 0.059  Millions
Sunlink Health Systems Inc   14.15 $ 76.738  Millions$ 5.423  Millions
Nanomix Corp  14.01 $ 0.108  Millions$ 0.008  Millions
Caredx Inc   13.98 $ 29.448  Millions$ 2.107  Millions
Bioxytran Inc   13.70 $ 0.221  Millions$ 0.016  Millions
Scynexis Inc   13.66 $ 8.722  Millions$ 0.639  Millions
Integrated Biopharma Inc  13.21 $ 38.351  Millions$ 2.903  Millions
Vivosim Labs Inc   13.19 $ 1.029  Millions$ 0.078  Millions
Procyon Corporation  13.13 $ 3.008  Millions$ 0.229  Millions
Halozyme Therapeutics Inc   12.94 $ 113.207  Millions$ 8.751  Millions
Sanara Medtech Inc   12.86 $ 3.392  Millions$ 0.264  Millions
Armata Pharmaceuticals Inc   12.74 $ 0.446  Millions$ 0.035  Millions
Applied Genetic Technologies Corporation  12.64 $ 12.711  Millions$ 1.006  Millions
Adma Biologics Inc   12.55 $ 7.715  Millions$ 0.615  Millions
Lumos Pharma Inc   12.40 $ 230.094  Millions$ 18.560  Millions
Hca Healthcare Inc   12.38 $ 71,945.000  Millions$ 5,813.250  Millions
Capricor Therapeutics inc   12.27 $ 5.796  Millions$ 0.472  Millions
Zeo Scientifix Inc   12.07 $ 0.060  Millions$ 0.005  Millions
Regeneron Pharmaceuticals Inc   11.95 $ 3,807.980  Millions$ 318.772  Millions
Chemed Corporation  11.88 $ 1,524.210  Millions$ 128.286  Millions
Immucell Corporation  11.86 $ 9.740  Millions$ 0.821  Millions

Date modified: 2026-08-29T17:19:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.